AdvanCell raised $112M in a Series C funding round co-led by SV Health Investors and Sanofi Ventures to expand its manufacturing capacity and accelerate clinical development.
Amount Raised
$112 Million
Round Type
Series C
SydneyBiotechnologyHealth CareTherapeuticsInvestors
Description
AdvanCell has successfully completed an oversubscribed $112 million Series C financing co-led by SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. This investment will support the company's efforts to enhance its manufacturing capacity and advance the development of its radionuclide therapies.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as AdvanCell that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
- StimOxyGen raised $2M on March 11, 2025.
- HelloBetter raised $6.4M (Funding Round) on March 5, 2025.
- TRIMTECH Therapeutics raised $31M (Seed) on March 5, 2025.
- Whitehawk Therapeutics, Inc. raised $100M on March 4, 2025.
- Callio Therapeutics raised $187M (Series A) on March 3, 2025.
Who to call at AdvanCell, and when
A new round usually means AdvanCell is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AdvanCell raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AdvanCell, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AdvanCell. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AdvanCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AdvanCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.